These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23504348)

  • 21. Downregulated expression of the cyclase-associated protein 1 (CAP1) reduces migration in esophageal squamous cell carcinoma.
    Li M; Yang X; Shi H; Ren H; Chen X; Zhang S; Zhu J; Zhang J
    Jpn J Clin Oncol; 2013 Sep; 43(9):856-64. PubMed ID: 23904342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
    Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
    Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?
    Shi M; Wang Z; Song L; Wang D; Sun Z
    Med Oncol; 2014 May; 31(5):951. PubMed ID: 24737010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
    Zhang H; Chen W; Duan CJ; Zhang CF
    World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma.
    Tang S; Gao L; Bi Q; Xu G; Wang S; Zhao G; Chen Z; Zheng X; Pan Y; Zhao L; Kang J; Yang G; Shi Y; Wu K; Gong T; Fan D
    PLoS One; 2013; 8(1):e52184. PubMed ID: 23341893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression.
    Zeng R; Huang JP; Li XF; Xiong WB; Wu G; Jiang ZJ; Song SJ; Li JQ; Zheng YF; Zhang JR
    Cell Biochem Funct; 2016 Apr; 34(3):133-41. PubMed ID: 26916087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
    Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
    Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
    Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
    Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
    Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
    Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.
    Zhang M; Yang Q; Zhang L; Zhou S; Ye W; Yao Q; Li Z; Huang C; Wen Q; Wang J
    J Exp Clin Cancer Res; 2014 Jan; 33(1):10. PubMed ID: 24438167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
    Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
    Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulated γ-catenin expression is associated with tumor aggressiveness in esophageal cancer.
    Fang WK; Liao LD; Gu W; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
    World J Gastroenterol; 2014 May; 20(19):5839-48. PubMed ID: 24914344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Kan T; David S; Cheng Y; Mori Y; Agarwal R; Paun B; Jin Z; Olaru A; Hamilton JP; Yang J; Abraham JM; Meltzer SJ; Sato F
    Cancer Res; 2008 May; 68(9):3214-24. PubMed ID: 18451147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.